Categories: News

Announcement no. 01/2022 – Disclosure of Home Member State by Coloplast Finance B.V.

DISCLOSURE OF HOME MEMBER STATE BY COLOPLAST FINANCE B.V.

NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES. NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY PERSON IN ANY JURISDICTION WHERE RELEASE, PUBLICATION OR DISTRIBUTION TO SUCH PERSON IS RESTRICTED BY ANY LAW OR REGULATION APPLICABLE IN SUCH JURISDICTION.

THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR ISSUE OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES.

Coloplast A/S has raised EUR 2.2 billion in debt financing through the issuance by Coloplast Finance B.V. of senior unsecured notes. The notes are unconditionally and irrevocably guaranteed by Coloplast A/S and listed at Nasdaq Copenhagen.

Pursuant to the transparency directive (EU Directive 2004/109/EC, as amended), issuers of securities admitted to trading on a regulated market in the European Union must disclose its home member state. Coloplast Finance B.V. hereby discloses that the home member state of the notes shall be Denmark.

Consequently, Coloplast Finance B.V. is subject to the disclosure requirements in the Danish Act on Capital Markets and executive orders issued pursuant hereto.

For further information, please contact

Investors and analysts
Aleksandra Dimovska
Director, Investor Relations
Tel. +45 4911 1800 /+45 4911 2458
Email: dkadim@coloplast.com

Press and media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com

Address
Coloplast Finance B.V.
Holtedam 1 Dageløkke
DK-3050 Humlebaek
Denmark
Company reg. (CCI) no. 85856819

Website
www.coloplast.com

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology and Voice & Respiratory Care. We operate globally and employ about 14,000 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-06.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachment

Staff

Recent Posts

Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces…

1 hour ago

Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities

Important note: Biophytis has set up financing in the form of Bonds redeemable in cash…

7 hours ago

Watertown Regional Medical Center Partners with HOPCo To Enhance Orthopedic and Spine Services

WATERTOWN, Wis. and PHOENIX, Ariz., June 19, 2024 /PRNewswire/ -- Watertown Regional Medical Center (WRMC)…

10 hours ago

Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024

SECAUCUS, N.J., June 19, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic…

10 hours ago

MULTI GRAMMY AWARD-WINNING ARTIST LIZZO KICKS OFF 5TH ANNUAL JUNETEENTH GIVEBACK FEATURING IMPACTFUL INITIATIVES AND INSPIRING CONVERSATIONS

LOS ANGELES, June 19, 2024 /PRNewswire/ -- For the fifth consecutive year, multi-Grammy Award and…

10 hours ago

MediOrbis(TM) Partners with Healthyr(TM) to Offer Proven Engagement, Longitudinal Care and Specialty

MediOrbis TM Partners with Healthyr to Offer Proven Engagement, Longitudinal Care and Specialty Telehealth Services…

13 hours ago